ePhysician nets $18 million from investors in third round

Article

Wireless e-health company ePhysician has closed its third round of funding, pocketing $18 million from a private investment group. The privately held company plans to use the additional funds to expand ePhysician's suite of clinical

Wireless e-health company ePhysician has closed its third round of funding, pocketing $18 million from a private investment group. The privately held company plans to use the additional funds to expand ePhysician's suite of clinical applications and to increase sales and marketing to its target market (physicians). ePhysician claims 8000 users and more than 400,000 prescriptions sent using its software. The application suite enables doctors to transmit electronic prescriptions securely over the Internet, to capture diagnosis and billing information, and to access drug reference information. The investors included Dresdner Kleinwort Capital (which led the group), Benchmark Capital, CVS, and Palm Ventures.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.